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SUMMARY  A 60-year-old male from the Mediterra-
nean area presented with edematous right leg and livid 
nodules and macules on the skin of upper and lower 
extremities. Biopsy specimen obtained from the right 
upper leg showed a pathohistologic finding indicative 
of Kaposi’s sarcoma. Polymerase chain reaction test-
ing revealed HHV-8 in the skin lesion. Serology for HIV 
was negative. Additional examinations did not reveal 
dissemination of the disease. Negative HIV serology, 
normal laboratory findings and absence of immunosup-
pressant therapy in the patient’s history confirmed the 
diagnosis of the classic form of Kaposi’s sarcoma.
KEY WORDS: classic Kaposi’s sarcoma; HHV-8 infec-
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 INTRODUCTION
 Kaposi’s sarcoma (KS) was first described in 
1872 by the Hungarian dermatologist Moritz Ka-
posi. He named it “idiopathic, multiple, pigmented 
sarcoma”. Although it was  more than a century 
ago its biology remains as enigmatic and conflict-
ing. In the early 1980s, the prevalence of KS be-
gan to increase dramatically and it soon became 
the most common malignancy among patients 
with the acquired immunodeficiency syndrome 
(AIDS), especially male homosexuals. However, 
its etiology and pathogenesis have not been elu-
cidated so far. In 1994, Chang et al. reported on 
a finding of human herpesvirus 8 (HHV-8) DNA 
sequences in tumor lesions and peripheral blood 
mononuclear cells from patients with KS (1). This 
shed more light on the possible etiopathogenet-
ic mechanisms of the disease. Four types of KS 
have been recognized: classic, endemic (African), 
iatrogenic, and epidemic (AIDS related).
We report on a case of classic KS in a 60-year-
old man, manifested with edematous right leg, and 
livid nodules and macules on the skin of the upper 
and lower extremities.
 CASE REPORT
 A 60-year-old male was admitted to University 
Department of Medicine, Merkur University Hos-
pital in Zagreb for the occurrence of livid nodules 
and macules on the skin of the upper and lower 
extremities. The patient came from a town on the 
Adriatic Sea in the Mediterranean area. Twenty 
years before, he had spilled caustic soda on his 
right leg and since then he observed occasional 
swelling of the leg. He was admitted to the hospital 
in his town because of bilateral pneumonia at the 
beginning of March 2003. During that period, first 
skin lesions occurred. His legs were edematous. 
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Several months later his right leg was still swollen. 
Phlebography of the right leg suggested partial 
recanalization after phlebothrombosis in the proxi-
mal upper leg. Extirpation of the great saphenous 
vein was performed, along with biopsy of the skin 
lesions. Pathologic finding suggested KS and he 
was referred to our hospital for further evaluation.
There  was a possibility of positive family history 
of the disease, as the patient’s father had some 
black spots on his legs. Physical examination re-
vealed numerous nodes and macules of 0.5-2 cm 
in diameter, distributed mostly over the edematous 
lower right extremity (Fig. 1).  
Figure 1. Multiple nodules  on right lower limb.
Laboratory findings, i.e.complete blood count, 
urinalysis, renal and hepatic function tests, were 
within the normal limits. Lung x-ray revealed post-
tuberculosis changes in the lymph nodes of the 
right hilus, without any infiltrative changes or ef-
fusion. Serology for human immunodeficiency vi-
rus (HIV) was negative. T lymphocyte count was 
normal, whereas CD4+ and CD8 cell count was 
slightly reduced and marginally elevated, respec-
tively. There was also a reduction in B lymphocyte 
count and an increase in NK-cell count. Ultrasound 
of the abdomen and heart was normal. Doppler 
sonography of the edematous lower extremity 
deep veins was normal, and so was ultrasound of 
the groin. Colonoscopy and endoscopic examina-
tion of the upper gastrointestinal tract revealed no 
pathologic changes suggestive of KS. 
 PCR testing detected HHV-8 in skin lesion
 DNA was isolated from a 10-μm section of 
formalin-fixed and paraffin-embedded biopsy  of 
a KS lesion, as described elsewhere (2). The sec-
tion was deparaffinized with Histoclear II (National 
Diagnostics, Hessle Hull, England), washed with 
100% ethanol, resuspended in digestion buffer (50 
mM Tris-HCl  pH 8.5, 1 mM EDTA, 0.5% Tween 
20) and digested with proteinase K (Roche Diag-
nostics, Mannheim, Germany) at final concentra-
tion of 200 μg/mL overnight at 37o C. The sample 
was boiled for 8 min before proceeding to PCR.
 PCR analysis for HHV-8 sequence
 Samples were submitted to 35 amplification 
cycels (94o C for 1 minute, 54o C for 1 minute, 72 
oC for 1 minute) according to Daibata et al. (3). 
HHV-8 DNA was amplified with the primers 5’-
AGCCGAAAGGATTCCACCAT-3’ and 5’-TCCGT-
GTTGTCTACGTCCAG-3’, resulting in generation 
of a 233-bp fragment. The PCR products were 
submitted to electrophoresis on a 3% ethidium 
bromide-stained agarose gel allowing for direct 
visualization of bands of an appropriate size. All 
procedures were performed under strict conditions 
to avoid false-positive results. As a positive am-
plification control, MSH2 gene (NCBI NM000251) 
was detected in both samples prior to HHV-8 as-
say. HHV-8 sequence was detected in the biopsy 
specimen of the KS lesion, whereas the patient’s 
peripheral blood was negative for HHV-8 (Fig.2).
Histologically, in a segment of the skin and subcu-
tis, a lobular tumor, built of vascular spaces and 
bordered by elongated and uniform cells, was 
found. There were also some mastocytes and rare 
lymphocytes. CD 105 and CD 31 were positive in 
tumor cells. The pathological finding correlates 
with Kaposi’s sarcoma (Fig. 3).
 In our opinion, negative HIV serology, normal 
laboratory findings, and absence of immunosup-
pressant therapy in the patient’s history strongly 
indicated the diagnosis of the classic form of the 
disease. In accordance with previous literature 
Figure 2. HHV-8 detection. Ethidium-bromide 
stained gel. M: molecular weight marker VIX 
(Roche Diagnostics, Mannheim, Germany), lane 
1: positive control, lane 2: peripheral blood of the 
patient, lane 3: Kaposi’s sarcoma lesion,  lane 4: 
negative control (water).
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reports, these results confirmed the possible etio-
pathogenetic role of HHV-8 in classic KS.
 DISCUSSION
 KS is a spindle-cell tumor thought to derive 
from endothelial cell lineage (4). Typical histo-
logic findings include proliferation of spindle cells, 
prominent slit-like vascular spaces, and extrava-
sated red blood cells (5). There is often a signifi-
cant component of inflammatory infiltrate includ-
ing lymphocytes and macrophages. This condition 
carries a variable clinical course ranging from 
minimal mucocutaneous disease to extensive or-
gan involvement. KS causes red or purple patches 
(lesions) on the skin and/or mucous membranes. 
Lesions may also develop in the oral cavity, gas-
trointestinal tract, lymph nodes, liver, lungs, kid-
neys, and spleen (6-8). The disease is clinically 
significant due to its possible multicentric involve-
ment of the internal organs being a cause of death 
in most cases.
 Based on the clinical and epidemiologic fea-
tures, four types of KS have been recognized. 
 - Classic KS is most commonly seen in Israel 
among elderly male Jews, Italians and Greeks but 
also in people of the Mediterranean, East Europe-
an and North American ancestry (9-11). The high-
est incidence rates of classic KS in Europe have 
been recorded in Sicily (Ragusa, 30.1 per million 
in men, 5.4 per million in women) and Sardinia 
(24.3 per million in men, 7.7 per million in women) 
(10). Histologic features of classic KS are not dif-
ferent from other forms of the disease (9,12). It 
usually occurs between the fifth and sixth decade 
of life, in Africans even earlier, in the third or fourth 
decade, more frequently in males. Data on male 
to female ratio are different, several reports state 
a 10:1 male to female ratio, and others a signifi-
cantly lower figure of 3:1 (4,9). Classic KS usu-
ally carries a protracted and indolent course. On 
rare occasions the disease can have aggressive 
behavior with disseminated skin lesions and in-
volvement of internal organs (13). Common com-
plications include venous stasis and lymphedema. 
As many as 30% of patients with classic KS may 
subsequently develop a second malignancy. Vis-
ceral involvement is uncommon. The treatment 
of classic KS depends on the site of lesions and 
clinical signs of the disease. Observation may be 
appropriate for asymptomatic individuals with little 
progression over a long period. Patients with le-
sions in limited areas are often treated with radia-
tion therapy (14,15).
 - Endemic African KS occurs in HIV serone-
gative men in Africa and may carry an indolent or 
aggressive course. 
 - Iatrogenic (immunocompromised) KS occurs 
after solid-organ transplantation or in patients re-
ceiving immunosuppressive therapy. However, 
individuals with congenital immunodeficient states 
are not at an increased risk of developing KS. The 
average time of KS following transplantation to de-
velop is 30 months. Visceral involvement is com-
mon.
 - Epidemic AIDS-related KS occurs in patients 
with advanced HIV infection, and is the most com-
mon presentation of KS. In the United States, KS 
serves as an AIDS-defining illness in 10%-15% 
of HIV-infected homosexual men. In Africa and 
developing regions, epidemic AIDS-related KS is 
common in heterosexual adults and occurs less 
often in children. Visceral involvement is common. 
AIDS-related KS is the most clinically aggressive 
form of KS (16). 
 HHV-8 is a gamma herpesvirus, closely relat-
ed to Epstein-Barr virus and Herpesvirus saimiri 
(1,17). Gamma herpesviruses are lymphotropic 
viruses that play a role in cell proliferation and ma-
lignancies. Several other diseases are associated 
with HHV-8 infection such as body cavity-based 
lymphomas, Castleman disease and leiomyosar-
comas that occur in HIV positive individuals (18). 
Later studies confirmed HHV-8 DNA sequences 
from lesions of classic, endemic, iatrogenic and 
HIV-associated forms of KS (19-25). The universal 
detection of HHV-8 suggests its central role in the 
development of KS. In contrast, careful PCR test-
ing does not detect HHV-8 in the normal tissues. 
Narančić-Skorić et al:   Acta Dermatovenerol Croat
Classic Kaposi’s sarcoma: a case report   2005;13(1):22-27
Narančić-Skorić et al:        Acta Dermatovenerol Croat
Classic Kaposi’s sarcoma: a case report    2005;13(1):22-27
ACTA DERMATOVENEROLOGICA CROATICA
Figure 3. Proliferation on small vessels bordered 
by elongated and uniform cells. (Hematoxylin - 
eosin stain; x250 )
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As with other cell-transforming human DNA virus-
es, infection with HHV-8 alone is not sufficient for 
the development of tumor and additional factors 
such as immunosuppression are required (19,26). 
Some other studies show that HHV-8 certainly has 
the means to overcome cellular control and im-
mune responses and thus to predispose carriers 
to malignancy, particularly KS (27). However, the 
interplay between infection with HHV-8 and other 
factors is complicated and our understanding of 
the induction and development of the disease is 
still incomplete. 
 In situ PCR and immunohistochemistry dem-
onstrate that HHV-8 is primarily localized to the 
spindle and endothelial cells (28-31). It is currently 
debated whether the KS tumor represents a reac-
tive process or it is a true monoclonal proliferation 
of a transformed cell (32-34). Human herpesvirus 
8 DNA can be amplified from KS tissue in different 
clinical stages of the disease (35). Furthermore, 
semiquantitative analysis has established that the 
HHV-8 DNA load is higher in patients with multi-
centric and visceral involvement compared with 
those with localized disease, and that the nodu-
lar stage has also a higher viral load than do the 
patch and plaque stages, thereby showing a cor-
relation between viral load and disease severity 
(36). Although the virus is tropic for lymphocytes, 
peripheral blood mononuclear cells (PBMCs) are 
only sporadically positive on PCR testing. Even in 
patients with KS, PBMCs are positive in only about 
50 percent (37). In addition, antibodies to HHV-8 
are associated with KS or being at increased risk 
of developing KS. In other words, serologic test-
ing demonstrates that infection with HHV-8 pre-
cedes and is predictive of the development of KS 
(38,39).  
 HHV-8 is principally acquired sexually. Anal 
intercourse may be particularly associated with 
transmission (40). HHV-8 is present in prostate tis-
sue, semen, feces and saliva. Data concerning a 
vertical route of transmission of HHV-8 are contra-
dictory (27). Intrafamilial person-to-person spread 
of the virus has also been suggested, since the 
HHV-8 seroprevalence of spouses, children, and 
siblings in families of KS patients is higher than 
in HHV-8 non-family controls (27). It can also be 
transmitted via solid organ transplantation (41). 
Most serologic studies suggest a global HHV-8 se-
roprevalence of 2% to 10% (42). There is a signifi-
cant geographic variation in the seroprevalence 
of the virus. In North America and in northern Eu-
rope 30%-50% of HIV positive homosexual men 
are seropositive for HHV-8, whereas among HIV 
negative homosexuals 15%-20% are HHV-8 posi-
tive. On the other hand, the infection appears to 
be uncommon in the general population. Current 
seroepidemiologic studies have suggested a high 
prevalence of HHV-8 in populations where classic 
KS is reported more frequently (the Mediterranean 
area), while there is a very high seroprevalence in 
many regions of Africa, and in China and Taiwan 
(approximately 50 percent) (41).
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